scispace - formally typeset
T

Tong Liu

Researcher at Sun Yat-sen University

Publications -  8
Citations -  483

Tong Liu is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 4, co-authored 4 publications receiving 444 citations.

Papers
More filters
Journal ArticleDOI

Genomic analysis of the immune gene repertoire of amphioxus reveals extraordinary innate complexity and diversity

TL;DR: The first comprehensive genomic survey of the immune gene repertoire of the Amphioxus Branchiostoma floridae suggests that the amphioxus, a species without vertebrate-type adaptive immunity, holds extraordinary innate complexity and diversity.
Journal ArticleDOI

An amphioxus TLR with dynamic embryonic expression pattern responses to pathogens and activates NF-κB pathway via MyD88

TL;DR: This study provides evidence for the immune-relation of amphioxus V-type TLRs, and suggests that Amphioxus TLR1 and MyD88 represent a basic evolutionary pathway.
Journal ArticleDOI

Genomic and Functional Uniqueness of the TNF Receptor-Associated Factor Gene Family in Amphioxus, the Basal Chordate

TL;DR: Comparisons of four distinct amphioxus TRAF groups suggest that genomic duplication and functional divergence of the TRAF family are important for the current form of the TNF-associated factor-mediated signaling pathways in humans.
Journal ArticleDOI

Bbt-TNFR1 and Bbt-TNFR2, two tumor necrosis factor receptors from Chinese amphioxus involve in host defense.

TL;DR: Two novel tumor necrosis factor receptors isolated from Chinese amphioxus were isolated and showed that they were regulated during development and finally had high expression in mucosa-rich tissues in adult stage, and may involve in the host defense of Chinese Amphioxus via distinct fashions.
Journal ArticleDOI

CD40×HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer

TL;DR: A novel mechanism of trastuzumab resistance in HER2-positive GC is revealed via the CCL2-ZC3H12A-TRAF6/3 signaling axis, and a CD40 ×HER2 bsAb is presented which showed great antitumor efficacy with few irAEs.